13F

Stock

Nektar Therapeutics

NKTR · held by 14 managers

Reported value

$116.1M

Holders

14

+1 new · −1 exited

Holders’ est. mark

$4.16M

Price effect on 3 books still in the name

Largest holder

$52.9M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY929.2K$52.9MHeld
FARALLON CAPITAL MANAGEMENT LLC791K$45MNew
Boxer Capital Management, LLC125K$7.11M$3.88MAdded$3.88M
Hudson Bay Capital Management LP107.7K$6.13MHeld
BANK OF AMERICA CORP /DE/48K$2.73MHeld
Persistent Asset Partners Ltd17.3K$982.7KHeld
BARCLAYS PLC16.7K$949K$279.8KAdded$716.2K
TUDOR INVESTMENT CORP ET AL5.43K$309.3KHeld
Allworth Financial LP676$38.5KHeld
IFP Advisors, Inc59$3.36KHeld
Boreal Capital Management LLC36$2.05KHeld
AllSquare Wealth Management LLC18$1.02KHeld
Medallion Wealth Advisors, LLC13$740$404Added$404
FNY Investment Advisers, LLC2.6K$148Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.